EBITDA di Signet International Holdings, Inc. è -$361.79
L'EBITDA è il reddito di una società prima di interessi, imposte, deprezzamenti e ammortamenti ed è una misura contabile calcolata utilizzando gli utili netti di una società, prima che vengano sottratti interessi passivi, imposte, ammortamenti e ammortamenti come proxy della redditività corrente di un'azienda.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
Signet International Holdings, Inc., a development stage company, focuses on developing advanced technologies, energy solutions, and medical devices. It focuses on development of bioscience and sport medicines, including Sterilal self-sanitizing devices, PASS smart denture mouth guards, handheld heart attack sensors, and melanoma detection systems. The company also offers InCharge magnetic-based battery device that provides energy; and develops applications for de-icing application of graphene for use in the airline industry, as well as technology for arc melted glass piles for structural foundations. Signet International Holdings, Inc., was founded in 2003 and is based in Palm Beach, Florida.